INTRODUCTION: Promoting Drug and Vaccine Innovation and Managing High Prices: Introducing a Special Symposium

, &
Journal of Law, Medicine and Ethics 51 (S2):5-6 (2023)
  Copy   BIBTEX

Abstract

This special JLME symposium addresses ways that federal policy can incentivize innovation in medical therapeutics and make pharmaceuticals more financially accessible.

Categories

Keywords

Reprint years

DOI

10.1017/jme.2024.18

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 93,069

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Government Support of Meaningful Drug and Device Innovation: Pathways and Challenges.Aaron S. Kesselheim - 2023 - Journal of Law, Medicine and Ethics 51 (S2):7-15.
The Government and Pharmaceutical Innovation: Looking Back and Looking Ahead.Bhaven N. Sampat - 2021 - Journal of Law, Medicine and Ethics 49 (1):10-18.
Doubling Down: Will Large Increases in the NIH Budget Promote More Meaningful Medical Innovation?Bhaven N. Sampat - 2023 - Journal of Law, Medicine and Ethics 51 (S2):21-23.
Pharmaceutical Innovation in Latin America and the Caribbean.Verónica Vargas & Jonathan Darrow - 2023 - Journal of Law, Medicine and Ethics 51 (S1):148-162.
Law, Science, and Innovation: Introduction to the Symposium.John A. Robertson - 2010 - Journal of Law, Medicine and Ethics 38 (2):175-190.
Medicine and pharmacy — facts and myths about the development of an innovative pharmaceutical industry in Poland.Włodzimierz Kubiak - 2005 - Science and Engineering Ethics 11 (1):41-51.
Rethinking Innovation Accounting in Pharmaceutical Regulation: A Case Study in the Deconstruction of Therapeutic Advance and Therapeutic Breakthrough. [REVIEW]John Abraham & Courtney Davis - 2011 - Science, Technology, and Human Values 36 (6):791-815.
Medical Innovation Then and Now: Perspectives of Innovators Responsible for Transformative Drugs.Shuai Xu & Aaron S. Kesselheim - 2014 - Journal of Law, Medicine and Ethics 42 (4):564-575.
Using Patent Data to Assess the Value of Pharmaceutical Innovation.Aaron S. Kesselheim & Jerry Avorn - 2009 - Journal of Law, Medicine and Ethics 37 (2):176-183.
When are Pharmaceuticals Priced Fairly? An Alternative Risk-Sharing Model for Pharmaceutical Pricing.Fanor Balderrama, Lisa J. Schwartz & Christopher J. Longo - 2020 - Health Care Analysis 28 (2):121-136.

Analytics

Added to PP
2024-03-05

Downloads
9 (#1,280,687)

6 months
9 (#355,594)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references